Roger Sawhney

This profile gathers the share dealings of Roger Sawhney across 2 companies, led by Arbutus Biopharma Corp and Omega Therapeutics, Inc. The record holds 5 filings, for trades running from 3 August 2021 to 1 October 2026.

The open-market record is one-sided, with 1 purchase worth €42k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 1 share grant and 2 option exercises.

Most recently, on 7 October 2026, the filings show a transaction worth €76k in Arbutus Biopharma Corp. The most recent open-market purchase was published on 3 August 2021, 1,902 days ago. The median gap between a trade and its publication by SEC (Form 4) is 5 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.